Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500282 ↗At a glance
Journal article in ChemMedChem, 2025. Written by Biswajit Naik and 8 co-authors. Institution: Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan, 305817, India. Major MEDLINE topics: Plasmodium falciparum, Antimalarials, Artemisinins, DNA-Binding Proteins. 35 references. Funded by: The Indian Council of Medical Research.
Abstract (original language)
Resistance to frontline antimalarials by malaria parasites is a major concern, prompting the search for novel antimalarial compounds targeting new drug targets. One promising target is the single‐stranded DNA‐binding protein (PfSSB) of Plasmodium falciparum , crucial for DNA replication process in apicoplast, an essential organelle. Using an integrative approach, PPG and 9‐HPF are identified, which inhibit the DNA binding property of PfSSB and exhibit antimalarial activity. Computational analyses reveal that both compounds possess strong binding affinity and favorable drug‐like properties. Biolayer interferometry assay and the gel retardation assays demonstrate that they have a stronger binding affinity and disrupt PfSSB's ssDNA binding ability. PPG and 9‐HPF show antimalarial activity against drug‐sensitive P. falciparum (3D7) with IC 50 values of 54.95 and 9.13 μM, respectively, and they can also effectively inhibit artemisinin‐resistant P. falciparum (C580Y) with a resistance index of 0.79 and 1.26, respectively. MTT cytotoxicity assays confirm that both compounds are nontoxic, and structural similarity analysis indicates that they are distinct from existing antimalarials, reducing cross‐resistance risk. Additionally, virtual screening of 59,807 compounds with similar structures to PPG and 9‐HPF identifies candidates with higher affinities for PfSSB. This study identifies PPG and 9‐HPF as structurally distinct antimalarials with the potential to combat drug‐resistant P. falciparum.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan, 305817, India.
- Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan, 305817, India.
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
- TERI School of Advanced Studies Institutional Area, Vasant Kunj, New Delhi, 110070, India.
ORCID profiles: Biswajit Naik, Dhaneswar Prusty
Funding
- The Indian Council of Medical Research
Cite
APA
Naik, B., Bhalerao, P., Shekhar, S., Varghese, S. A., Makwana, S., Mandal, C. C., Bhatt, T. K., Dhar, S. K., & Prusty, D. (2025). Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains. ChemMedChem. https://doi.org/10.1002/cmdc.202500282
Vancouver
Naik B, Bhalerao P, Shekhar S, Varghese SA, Makwana S, Mandal CC, et al. Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains. ChemMedChem. 2025. doi:10.1002/cmdc.202500282
BibTeX
@article{Naik2025,
author = {Naik, Biswajit and Bhalerao, Preshita and Shekhar, Shashank and Varghese, Stephy A and Makwana, Sweta and Mandal, Chandi C and Bhatt, Tarun Kumar and Dhar, Suman Kumar and Prusty, Dhaneswar},
title = {Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500282}
}
EUVIMED